Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by alleyesonmeon Jan 12, 2022 7:58pm
109 Views
Post# 34310841

RE:RE:RE:RE:I believe that something is afoot

RE:RE:RE:RE:I believe that something is afootThe majority of the debenture was paid with in shares...to do it ahead of schedule at such a depressed price seems idiotic unless its to secure a major money deal with BIG pharma. It's a routine demand from large corporations when inking deals with small companies....clean strong balance sheet....they don't want continuance of operations to be in jeopardy and this isn't a concern for labs anymore....I agree with Jaycee that something BIG is brewing....I think apotex ...purely speculative...the reason for this accelerated debenture repayment will come out and all possible reasons I see are very good...disgruntled, diluted shareholders may not be so grumpy once this news surfaces and LABs emerges from the ashes as a powerhouse cutting edge pharmaceutical company on the forefront of cannabis based medications.
<< Previous
Bullboard Posts
Next >>